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Background: The microscopic agglutination test (MAT), the standard method for serological diagnosis of leptospirosis,
may present limitations regarding its sensitivity. Current studies suggest that Leptospira immunoglobulin-like (Lig)
proteins and LipL32 are of particular interest as serodiagnostic markers since they are present only in pathogenic
species of the Leptospira genus. The purpose of this study was to identify leptospiral immunodominant proteins
that are recognized by canine sera from diseased dogs.
Results: A total of 109 dogs were studied, including seroreactive dogs (MAT ≥800) and dogs with no seroreactivity
detectable by MAT. Eight recombinant fragments (31–70 kDa) of pathogenic Leptospira were tested for their use
as diagnostic markers for canine leptospirosis using the Multi-antigen Print Immunoassay (MAPIA) platform: LigB
[582-947aa] from L. interrogans serovar Pomona, L. interrogans serovar Copenhageni and L. kirschneri serovar
Gryppotyphosa, LigB [131-649aa] from L. interrogans serovar Copenhageni, L. interrogans serovar Canicola and L.
kirschneri serovar Gryppotyphosa, LigA [625-1224aa] L. interrogans serovar Copenhageni and LipL32 from L. interrogans
serovar Copenhageni. The data were analyzed and ROC curves were generated. Altogether, LigB [131-649aa] L. interrogans
Canicola, LigB [131-649aa] L. kirschneri Gryppotyphosa and LipL32 L. interrogans Copenhageni showed best accuracy
(AUC = 0.826 to 0.869), with 70% specificity and sensitivity ranging from 89% to 95%.
Conclusions: These results reinforce their potential as diagnostic candidates for the development of new methods for
the serological diagnosis of canine leptospirosis.
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Leptospirosis in dogs may manifest with a wide range of
symptoms, from fever to liver and kidney failure, jaundice
and bleeding. It is a widespread life-threatening disease
with zoonotic potential, particularly in tropical areas [1,2],
where characteristics such as climate, topography and also
regularity of veterinary assistance affect the prevalence of
the disease [3].
The early diagnosis becomes a priority for allowing
therapeutic incursions and more effective control measures
[4]. However, the most employed serological method for
the diagnosis of leptospirosis – the microscopic agglutin-
ation test (MAT) - may not present adequate sensitivity,* Correspondence: medeiros@bio.fiocruz.br
2Fiocruz, Bio-Manguinhos, Laboratory of Recombinant Technology, Avenida
Brasil, 4365, Manguinhos, 21045-900 Rio de Janeiro, RJ, Brasil
Full list of author information is available at the end of the article
© 2014 Thomé et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.particularly in detecting early disease. Additionally, it
requires specific laboratory facilities and is too labori-
ous, offering risk to the operator [5]. The MAT detects
agglutinating antibodies and paired serum samples with
an interval of at least 10 days are needed to diagnose
acute infection [6]. Due to these limitations, recent
studies have applied proteomic approaches in order to
identify novel protein antigens for the development of
alternative diagnostic tests [7]. Currently, a variety of
alternative methods based on recombinant proteins are
under development, such as ELISAs and immunoblotting
assays, and have shown encouraging results [8,5,9,10].
Several reported serodiagnostic assays target the lepto-
spiral immunoglobulin-like (Lig) proteins as antigen [10].
It has been demonstrated that the lig genes are highly
conserved among different leptospiral species and present
exclusively among pathogenic leptospires [11]. Besides,Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Homogeneity of the recombinant proteins used in
MAPIA. SDS PAGE 12,5% of each purified recombinant protein used
in this study.
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ium and have been identified not only as diagnostic
markers during early leptospirosis but also as potential
candidates for vaccine development [8,12]. Additionally,
LipL32 is also a protein with remarkable importance in
this context, since it is the most abundant outer mem-
brane lipoprotein of leptospires and seems to be highly
immunogenic [13,14].
The purpose of this study was to identify immunodomi-
nant proteins of leptospires that are recognized by sera
from healthy or diseased dogs, which can be employed in
the development of a novel diagnostic test for canine
leptospirosis.
Results
According to the MAT results, reactions against members
of serogroup Icterohaemorrhagiae (serovars Icterohae-
morrhagiae and Copenhageni) were the most common,
representing 86.7% (26/30) of all seroreactive samples.
Seroreactivity against serogroups pomona (10%, 3/30) and
grippotyphosa (3.3%, 1/30) were also detected.
The purified recombinant proteins used for printing
the MAPIA strips were analyzed by SDS PAGE 12.5%
and showed high homogeneity (Figure 1). The MAPIA
densitometry results showed that, in general, group N2
(housed vaccinated dogs) had lower IgM background
against the recombinant proteins than groups N3 (stray
dogs) and N4 (dogs with other febrile syndromes) and
group P1 (seropositive dogs) had a stronger IgM reactivity
(Figure 2). The reactivity detected for group P1 (seroposi-
tive dogs) against LigB [131-649aa] L. kirschneri Gryppo-
typhosa, LigB [131-649aa] L. interrogans Canicola and
LipL32 L. interrogans Copenhageni were the most intense,
with a higher median reactivity when compared to the
control groups (Figure 2).
Using a cut-off of 1.5 standard deviations above the
average reactivity of the control samples, we were able
to establish sensitivity and specificity values for each of
the recombinant proteins studied when comparing the
seropositive group (P1) with each of the control groups
(N2, N3 and N4). The results are summarized in Table 1.
The specificity did not vary significantly when analyzing
the different control groups. Conversely, sensitivity varied
considerably, showing lower values when group N3 (stray
dogs) was the considered group. Even though sensitivity is
strictly related to the number of true positive samples, that
is, reactivity among the reference samples in group P1, the
use of different control groups lead to different cut-offs,
which may ultimately influence the sensitivity. Indeed,
background reactivity was higher in group N3 (Figure 2),
increasing the cut-off value compared to groups N2
and N4 (Table 2). In general, Lig recombinant proteins
[131-649aa] L. interrogans Canicola, Lig [131-649aa] L.
kirschneri Gryppotyphosa and LipL 32 L. interrogansCopenhageni provided best sensitivity rates, for all control
groups, except for group N3, in which Lig [131-649aa] L.
interrogans Copenhageni overpassed LipL32.
In order to assess the diagnostic accuracy of the re-
combinant proteins, individual antigen ROC curves were
generated and the corresponding AUC was determined.
Antigens were then ranked by decreasing AUC and mul-
tiple antigens ROC curves were generated. Figure 3A
shows the individual ROC curves for each of the recom-
binant proteins when we compared the seropositive dogs
(group P1) against all the other groups combined as a
single group (groups N2, N3 and N4). The AUC values
are shown in Table 1. LipL32 L. interrogans Copenhageni
provided best accuracy (AUC= 0.869), followed by LigB
[131-649aa] L. kirschneri Gryppotyphosa (AUC = 0.855)
and LigB [131-649aa] L. interrogans Canicola (AUC =
0.826). Furthermore, when group P1 was compared to
groups N2, N3 and N4 separately, the same antigens
showed best performance. The combination of those three
antigens improved the diagnostic accuracy when consider-
ing all control samples in a single group (Figure 3B) and
also when group P1 was compared to group N3 (stray
Figure 2 Box plots representing the overall reactivity detected for each group of samples against the recombinant proteins. Bars
indicate the maximum or minimum values; the purple area indicates the 25th percentile; the green area indicates de 75th percentile; the line
between purple and green areas indicates de median. Sample groups: P1, seropositive dogs; N2, housed vaccinated dogs; N3, stray dogs; N4,
dogs with other febrile syndromes.
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LipL32 and LigB [131-649aa] L. kirschneri Gryppotyphosa
provided the best performance. When we consider group
N4 (dogs with other febrile syndromes) as control, how-
ever, the addition of extra antigens did not impact the
diagnostic performance of LipL32 (Figure 4).
Discussion
In the present study we used three different groups of
seronegative samples. Group N2 was a very well-defined
group, with reliable information regarding shelter,
immunization and veterinary assistance. Although Rio
de Janeiro, as other tropical cities, is an endemic city for
leptospirosis and it is not possible to exclude the possibil-
ity of previous contact of those dogs with leptospires,
those animals present a low epidemiological risk of infec-
tion due to smaller chances of direct or indirect contact
with rodents. Accordingly, higher sensitivity and specifi-
city rates were obtained when the seropositive group P1Table 1 Diagnostic performance of each antigen for all the co
Antigens P1 vs N2 P1 vs
AUC Se/Spe AUC
LigB [582-947aa] L. interrogans Pomona 0.841 63/90 0.636
LigB [131-649aa] L. interrogans Canicola 0.879 73/87 0.763
LigB [582-947aa] L. interrogans Copenhageni 0.875 67/90 0.682
LigB [131-649aa] L. interrogans Copenhageni 0.827 63/87 0.707
LigA [625-1224aa] L. interrogans Copenhageni 0.875 63/93 0.654
LipL32 L. interrogans Copenhageni 0.951 77/93 0.787
LigB [582-947aa] L. kirschneri Gryppotyphosa 0.759 63/90 0.601
LigB [131-649aa] L. kirschneri Gryppotyphosa 0.919 80/93 0.787
Se: sensitivity; Spe: specificity. Sample groups: P1, seropositive dogs; N2, housed vawas compared against group N2. It is also interesting to
highlight that all animals in group N2 had been vaccinated
within 1 year before sample collection and, therefore, the
antigens with high diagnostic performance identified when
group N2 was used as control were actually able to differ-
entiate between a current acute leptospirosis case and a
vaccinated non-diseased dog.
Conversely, animals from Group N3 (stray dogs) pre-
sented the lower accuracy results. Information regard-
ing the epidemiological status of those animals was very
scarce, as well as data about previous diseases or immuni-
zations history. Therefore, those dogs may have been
exposed to many variables, and possible biases cannot be
excluded. Nevertheless, it is important to note that in the
daily practice information may not be available for the
practitioner when a decision regarding the diagnostic test
must be taken. In that situation, results of group N3 rep-
resent a non-ideal but very common scenario in veterinary
practice, justifying its inclusion in the present study.ntrol groups studied
N3 P1 vs N4 P1 vs N2, N3 and N4 combined
Se/Spe AUC Se/Spe AUC Se/Spe
27/90 0.781 43/89 0.749 40/90
53/93 0.840 70/89 0.826 67/91
27/90 0.704 33/95 0.764 37/91
47/87 0.811 57/89 0.777 50/87
20/90 0.714 40/95 0.764 37/89
43/93 0.869 70/95 0.869 60/91
27/97 0.742 53/89 0.695 40/92
57/93 0.861 70/89 0.855 63/90
ccinated dogs; N3, stray dogs; N4, dogs with other febrile syndromes.
Table 2 Established cut-off for each of the proteins and control groups used in this study


















N2 0.024 0.033 0.023 0.034 0.076 0.044 0.010 0.051
N3 0.079 0.087 0.101 0.072 0.180 0.127 0.072 0.134
N4 0.046 0.052 0.081 0.050 0.111 0.077 0.025 0.086
MAT-negative dog groups combined
Groups N2, N3, N4 0.056 0.064 0.075 0.055 0.134 0.092 0.046 0.100



















Figure 3 ROC curves showing the diagnostic accuracy of each recombinant protein analyzed individually (A) or in combination (B)
when combining the 3 control groups N2, N3 and N4 as a single group. In A, proteins are sorted from left to right by decreasing AUC
values. The combination of the first 3 antigens (B, dark brown) provides best accuracy. Sample groups: P1, seropositive dogs; N2, housed
vaccinated dogs; N3, stray dogs; N4, dogs with other febrile syndromes.
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presented good results and discriminatory abilities. Al-
though its potential for diagnosis tests is still controversial,
the protein is known to be an immunodominant antigen
in leptospirosis, particularly for the acute syndrome of the
disease in human beings [12,15-17]. It has been reported
that IgM antibodies specific to the C-terminal region of
LipL32 can be detected during the acute infection, so that
LipL32 could be effectively used as a diagnostic marker
[18]. Furthermore, it has been successfully employed as an
amplification target in molecular diagnosis (PCR) in hu-
man and animal samples, with excellent specificity, since
it is present exclusively in pathogenic leptospires [19,20].
LipL32 alone or associated to LigB [131-649aa] of L.
interrogans Canicola and/or L. kirschneri Gryppotyphosa
showed the best discriminatory potential. The fragment
LigB [131-649aa] of L. interrogans Canicola and/or L.
kirschneri Gryppotyphosa is encoded by a genetic region(131-649aa) that shares 100% identity with LigA. Though
LigA is present only in L. interrogans and L. kirschneri,
LigB has been detected in all pathogenic Leptospira spe-
cies [11]. Furthermore, the fragment LigB [131-649aa] has
been described as a highly sensitive marker for leptospir-
osis in humans, particularly in the first week of the course
of infection [8].
Our findings for canine leptospirosis are in contrast
with recent studies conducted in human beings, in which
the LigB [582-947aa] and LigA [625–1224] proteins were
the basis of a novel rapid test and showed promising re-
sults [9]. Here, we show that those fragments are not as
strongly antigenic in dogs.
The predominance of seroreactivity against serogroup
icterohaemorrhagiae detected by MAT was expected and
agrees with previous studies conducted with clinically sus-
pect Brazilian dogs [21]. As a consequence, even though it
was not the original purpose of this study, the MAPIA
Figure 4 ROC curves showing the diagnostic accuracy of the recombinant proteins when analyzed in combination. Proteins were ranked
by decreasing individual AUC and the impact of adding antigens, one at a time, was analyzed. The best combination is shown in dark brown.
Sample groups: P1, seropositive dogs; N2, housed vaccinated dogs; N3, stray dogs; N4, dogs with other febrile syndromes.
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syndrome of canine leptospirosis. Therefore, it is im-
portant to highlight that our results may not represent
the chronic/subclinical disease that is determined by
the host-adapted serovar Canicola. It is interesting,
though, the fact that LigB [131-649aa] of L. kirschneri
Gryppotyphosa and L. interrogans Canicola presented
better results than LigB [131-649aa] L. interrogans
Copenhageni. Although theoretically a protein obtained
from Copenhageni strains should be more useful for de-
tecting dogs infected by icterohaemorraghiae serogroup, itwas not observed in the current study. Noteworthy that
LigB obtained from L. kirschneri has a 91% identity with
respect to L. interrogans serovar Copenhageni [11], and
the region between amino acids 131-649aa of LigB frag-
ment corresponding to LigB domains 2–6 has an even
higher identity (96%), which could possibly explain the ob-
tained results.
Conclusions
MAPIA identified important immunodominant antigens in
canine leptospirosis. LipL32 presented the most consistent
Thomé et al. BMC Veterinary Research 2014, 10:288 Page 7 of 9
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for diagnostic tests. Alternatively, LigB [131-649aa] of L.
interrogans Canicola and L. kirschneri Gryppotyphosa may
increase accuracy when present in a combined antigenic
formula for detecting leptospirosis in dogs.
Methods
Study design
Canine serum samples were collected in veterinary hos-
pitals in Rio de Janeiro, Brazil. After collection, MAT
was conducted as described later in this section in order
to determine dog’s sero-reactivity to leptospires. Samples
were grouped according to patient’s data provided by the
assistant veterinarian (when available) regarding anamnesis,
clinical presentation and vaccination history; and on the
MAT results. Finally, the Multi-antigen Print Immuno-
assay (MAPIA) was performed and the samples’ reactivity
to different recombinant proteins of the pathogenic strains
Leptospira interrogans serovar Copenhageni, Pomona and
Canicola and Leptospira kirschneri serovar Gryppotyphosa
was evaluated.
Ethics statement
The study protocol was approved by the Ethics Committee
on Animal Use at Fluminense Federal University, Brazil
(Protocol 154/2011). Written or verbal consent from the
owners of the dogs was received to use blood in this study.
Animal
Blood samples were obtained from 109 adults 2-17y,
including (i) 30 sero-reactive dogs with MAT titer ≥800,
showing clinical signs compatible with anorexia, fever,
dehydration and icterus (based on the clinician’s judgment)
and which may or may not have been vaccinated (Group
P1); (ii) 30 housed non-diseased dogs with titer ≤100, which
had been vaccinated (commercial bacterins) in the last year
and showed no clinical alteration, so considering this group
as healthy vaccinated animals (Group N2); (iii) 30 stray
dogs with MAT titer ≤100 and unknown history of vac-
cination, considering this group as unvaccinated healthy
animals (Group N3), and (iv) 19 dogs sero-negative for
leptospirosis (MAT titer ≤100) but presenting a differ-
ent febrile syndrome (Group N4), as canine distemper
disease (n = 1), ehrlichiosis (n = 8), anaplasmosis (n = 6)
or babesiosis (n = 4). The febrile syndromes were diagnosedTable 3 Groups of canine serum samples used in this study
Group # serum samples Diagnosis MAT titer
P1 30 Leptospirosis ≥800
N2 30 Healthy ≤100
N3 30 Healthy ≤100
N4 19 Other febrile syndromes ≤100
N/A: Not available.by reference laboratories through the direct detection of
the pathogenic agent on blood and/or commercial ELISA
serological tests. Animals’ informations are summarized in
Table 3. The diseases have similar clinical alterations to
leptospirosis, justifying the importance of this group in
the study.
The blood was withdrawn from cephalic vein. Serum
was then separated by centrifugation and stored at −20°C
until use.
Microscopic agglutination test
For detection of anti-Leptospira antibodies, microscopic
agglutination test (MAT) was conducted according to
the recommendations for international standards [22].
The complete panel included 28 serovars representing all
the 24 known serogroups (from Royal Tropical Institute -
KIT, Amsterdam, Netherlands). Bacteria were cultured in
liquid Ellinghausen-McCullough-Johnson-Harris (EMJH)
and used as antigens. Each serum sample was initially di-
luted 1:50 in buffered saline and 50 uL of this solution
were transferred into vinyl microplates containing 96 wells
(Corning Incorporated, Corning, NY, USA). Immediately
after, an equal volume of each antigen was added to the
corresponding well, with a final dilution of 1:100. The
microplates were incubated at 37°C for 90 minutes and
observed under dark-field microscopy. Serum samples
were initially analyzed at a dilution of 1:100, and those
that showed agglutination level equal to or higher than
50% were then diluted again in a geometrical ratio of two
(1:200, 1:400 and 1:800). Samples were considered as re-
active when reached titers of 200 or 400. Reactions that
presented titres ≥800 were considered as strongly reactive
and considered as an indication of acute infection [22].
Cloning, expression and purification of recombinant
proteins
DNA fragments obtained by PCR amplification were
cloned into the pET100-TOPO plasmid (Invitrogen) for
the expression of recombinant proteins containing an
N-terminal His6 tag. All plasmid constructs were con-
firmed by DNA sequencing using an ABI 3100 sequencer
(Applied Biosystems). The Lig plasmid constructs were
cultured at 37°C to the mid-log phase, and expression was
induced using isopropyl-β-D-thiogalactopyranoside (IPTG)
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harvested by centrifugation at 10,000xg and resuspended in
20 mM Tris, 1 mM EDTA pH 8.0 and 0.1% Triton X-100.
After incubating for 30 minutes at 4°C, the cells were
disrupted by sonication (Sonics & Material). The lysate
was centrifuged at 10,000 × g for 20 minutes at 4°C. The
recovered soluble fraction was applied to a Ni2+-charged
column (Histrap HP, GE Healthcare) in a High pressure
liquid chromatography (HPLC) system and washed with
10 column volumes of buffer (PBS, pH 7.4, 20 mM
imidazole). The following stages had been made using
steps varying from to 20 mM to 300 mM stepwise gradi-
ent of imidazole until the protein was eluted. The purified
proteins were checked for homogeneity in 12.5% SDS-
PAGE and quantified by the BCA method (BCA Thermo
Scientific Pierce, Rockford, IL, USA) according to the
manufacturer’s recommendations.
Recombinant proteins
Eight recombinant proteins, designed based on the do-
mains of the Lig proteins, were employed in this study:
LigB [582-947aa] from L. interrogans serovar Pomona,
L. interrogans serovar Copenhageni and L. kirschneri
serovar Gryppotyphosa, LigB [131-649aa] from L. interro-
gans serovar Copenhageni, L. interrogans serovar Canicola
and L. kirschneri serovar Gryppotyphosa, LigA [625-
1224aa] from L. interrogans serovar Copenhageni and
LipL32 [1-272aa] from L. interrogans serovar Copenhageni.
These fragments were cloned, expressed in Escherichia coli
expression system and purified by affinity chromatography
as described above.
Multi-antigen print immunoassay
The assay was performed as described previously [23].
Briefly, antigens were immobilized on a nitrocellulose
membrane (Schleicher & Schuell, Keene, N.H.) so that
each strip contained 100 ng of each of the proteins.
Phosphate buffer saline was spotted on the nitrocellulose
membrane as a negative control reaction (blank). A
semi-automatic micro-aerolization device (Automatic
TLC Sampler 4, CAMAG, Muttenz, Switzerland) was
used to generate parallel bands with no visible marks. The
membrane was cut into 0.4 cm wide strips perpendicularly
to the antigen bands. Protein A was added as a control
band of antigen-antibody reaction. The strips were blocked
overnight with 4% reduced-fat bovine milk diluted in 0.05%
PBS Tween 20 (Sigma-Aldrich) and then incubated for 2 h
at room temperature with individual serum samples
(diluted 1:400 in blocking solution) and 150 ug/ml of
E. coli extract. After washing, the strips were incubated
for 1 h with alkaline phosphatase–labeled anti-dog IgM
antibody (Alkaline Phosphatase Dog Conjugated Antibody
IgM, Bethyl Laboratories, TX, USA) diluted 1:50,000 in
0.25% BSA-0.05% PBS Tween 20 (Sigma-Aldrich). Afterwashing, the strips were incubated with a substrate for
alkaline phosphatase (Western Blue Stabilized Substrate
for Alkaline Phosphatase, Promega, WI, USA) for 10–15
minutes and the reaction was stopped with distilled water.
The reactivity was quantified by densitometry (Bio-Rad
GS-800 Calibrated Densitometer, Hercules, CA, USA) and
data analysis was performed with Quantity One 1-D
Analysis software, Bio-Rad.
Statistical analysis
For densitometry analysis, relative density was determined
by subtracting the background detected for the blank
reactions from the reactivity against the recombinant
proteins. Cut-off points were established considering
the average reactivity of the control samples plus 1.5
standard deviations. Sensitivity and specificity were cal-
culated and defined for each control group individually
as well as in combination. Receiver operating characteris-
tic (ROC) curves were made with the “ROCR” R package
in the R environment using the “leave one out cross-
validation” (LOOCV) approach. ROC graphs were created
by plotting the true positive rate (sensitivity) against the
false positive rate (specificity) at various threshold settings
in order to illustrate the recombinant proteins diagnostic
performance, which was assessed by the area under the
curve (AUC).
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